Company Filing History:
2 out of 97 
1 out of 289 
1 out of 1 
Years Active: 2013-2016
Title: The Innovative Contributions of Erik Boettger
Introduction
Erik Boettger is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmacology, particularly in the treatment of bacterial infectious diseases. With a total of 4 patents to his name, Boettger's work is characterized by innovative approaches to antibiotic development.
Latest Patents
One of Boettger's latest patents focuses on the treatment of bacterial infectious diseases. This novel pharmacological treatment utilizes apramycin or its derivatives, which exhibit significantly low toxicity in humans. Another important patent involves a screening assay for ribosomal antibiotics. This invention outlines a method for identifying ribosomal antimicrobial substances that selectively target microbial ribosomes while sparing mitochondrial and cytosolic ribosomes. The method compares the interaction of candidate antimicrobial substances in various bacterial strains, enhancing the identification of effective treatments.
Career Highlights
Throughout his career, Erik Boettger has worked with prestigious institutions such as the University of Zurich and ETH Zurich. His research has contributed to advancements in antibiotic therapies, addressing critical health challenges posed by bacterial infections.
Collaborations
Boettger has collaborated with notable colleagues, including Andrea Vasella and Sven N Hobbie. These partnerships have fostered a collaborative environment that enhances the innovation process in his research endeavors.
Conclusion
Erik Boettger's contributions to the field of pharmacology and antibiotic development are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving treatment options for bacterial infections.